TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06203691

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Supplementation with Nirvana Super Pro Liquid Supplements
Description: Intervention will measure strength pre \& post operatively. Intervention group will receive liquid supplements (3oz daily shots) pre (Prepare) and Post (Recover) operatively.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Non-Supplementation Group
Description: Intervention will measure strength pre \& post operatively. Intervention group will not receive liquid supplements.
Study: NCT06547463

Intervention type: OTHER
Intervention: nasal oxygenation device
Description: Use of the nasal oxygenation device on one of the two nights during which polysomnography will be performed.
Study: NCT06104059

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Nociception level index (NOL™)
Description: If a NOL value \>25 persists for \>1 minute a bolus of iv fentanyl 0.5mcg/kg will be given and reassessment of the NOL value will continue every 5 minutes. If NOL index value: 10-25 is not reached within 10 minutes, fentanyl 0.5mcg/kg iv is re-administered.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl
Description: Bolus doses of iv fentanyl 0.5 mcg/kg will be administered based on the judgment of the anesthesiologist in charge.
Study: NCT05724797

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NRS-033
Description: A single dose of NRS-033 will be administered

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A single dose of matching placebo will be administered
Study: NCT06098521

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CONSENT
Description: The CONSENT program is a risk-, need- and responsivity (RNR) based CBT program primarily focused on reducing risk of sexual reoffending, that consists of 18-26 one-to-one sessions in correctional settings.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CONSENT
Description: The CONSENT program is a risk-, need- and responsivity (RNR) based CBT program primarily focused on reducing risk of sexual reoffending, that consists of 18-26 one-to-one sessions in correctional settings.
Study: NCT05139173

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Smart Physiotherapy Activity Recognition System (SPARS)
Description: Wearable smart watch that records inertial data such as (accelerometer, gyroscope magnetometer) and the exercise is started on the tablet, while patients are performing physiotherapy exercises.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smart Physiotherapy Activity Recognition System (SPARS)
Description: Wearable smart watch that records inertial data such as (accelerometer, gyroscope magnetometer) and the exercise is started on the tablet, while patients are performing physiotherapy exercises.
Study: NCT04710797

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Completion staging surgery including systematic pelvic and para-aortic lymphadenectomy
Description: * open or minimally invasive surgical approach~* cytologic examinations~* All peritoneal surfaces should be visualized, and any peritoneal suspicious for metastasis should be selectively excised or biopsied~* BSO and hysterectomy~* For selected patients desiring to preserve fertility, USO or BSO with uterine preservation may be considered~* Omentectomy~* Para-aortic lymph node dissection should be performed by stripping the nodal tissue from the vena cava and the aorta bilaterally to at least the level of the inferior mesenteric artery and preferably to the level of the renal vessels~* The preferred method of dissecting pelvic lymph nodes is bilateral removal of lymph nodes overlying and anterolateral to the common iliac vessel, overlying and medial to the external iliac vessel, overlying and medial to the hypogastric vessels, and from the obturator fossa at a minimum anterior to the obturator nerve

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Comprehensive staging surgery with no Lymphadenectomy
Description: * open or minimally invasive surgical approach~* cytologic examinations~* All peritoneal surfaces should be visualized, and any peritoneal suspicious for metastasis should be selectively excised or biopsied~* BSO and hysterectomy~* For selected patients desiring to preserve fertility, USO or BSO with uterine preservation may be considered~* Omentectomy~* In open approach surgery, exploring the pelvic and Para-aortic lymph node with hand. In minimally invasive surgery, the peritoneal above the pelvic and Para-aortic lymph node area should be open and visualized.Biopsy and frozen section of the suspicious lymph nodes
Study: NCT04256005

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will complete one of two exercise conditions (50% Delta GET or 105% VO2peak).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will complete one of two exercise conditions (50% Delta GET or 105% VO2peak).
Study: NCT06412068

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combined anti-PD-1 and R-CHOP
Description: Sintilimab,200mg, d1, intravenous drip; Rituximab,375mg／㎡, d1,intravenous drip; Cyclophosphamide,750mg／㎡,d2,intravenous drip; Doxorubicin,50mg／㎡ （or Liposome doxorubicin ，40 mg／㎡）,d2,intravenous drip; Vincristine,1.4mg／㎡, d2（Maximum dose 2mg),intravenous drip; Prednisone, 60mg/ m2 , d1-d5,oral administration.
Study: NCT05948436

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Clamping the uterine artery bilaterally during Cesarean section
Description: We clamped the uterine artery by Darmklemmen clamp, which grasps the tissue delicately without damage, after the delivery of the baby before the delivery of placenta. The clamp is released after the suturing of Munro-Kerr incision is finished, before bleeding control. The duration of clamping time is recorded.
Study: NCT05423301

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Respiratory care consists of manual and instrumental bronchial clearance techniques: Expiratory Flow Enhancement (EFE), suctioning, manual cough assist techniques, instrumental clearance techniques (suctioning and Cough Assist) and swallowing disorder management.)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The control group will receive early respiratory care and rehabilitation by nurses, nurses' aides and doctors until D7. Respiratory care includes aerosol therapy, oral and pharyngeal clearance with aspirations, verbal coughing and sputum removal, and possibly bronchial fibroscopy for clearance if necessary. Early rehabilitation consists of alternating postures in bed, passive chair positioning (patient lift), or active positioning via a bed rail and standing.
Study: NCT05584774

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: PELDAN
Description: percutaneous endoscopic lumbar dissectomy and annuloplasty and nucleoplasty

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PELDAN
Description: percutaneous endoscopic lumbar dissectomy and annuloplasty and nucleoplasty
Study: NCT05213507

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: aerosol inhaled Amikacin Sulfate Injection
Description: 0.4g Amikacin sulfate injection + 5ml saline, aerosol inhalation, b.i.d., 7-10 days per month, for 3 months.

Intervention type: OTHER
Group type: OTHER
Intervention: conventional therapy
Description: According to the personal characteristics of subjects and guidance of The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021, the doctor in charge prescribes appropriate medication, including but not limited to bronchodilators, inhaled corticosteroids and long-term oxygen therapy.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional therapy
Description: According to the personal characteristics of subjects and guidance of The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2021, the doctor in charge prescribes appropriate medication, including but not limited to bronchodilators, inhaled corticosteroids and long-term oxygen therapy.
Study: NCT04603079

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention for COVID-19 preventive protocols
Description: The intervention will comprise (A) digital communication of written material and (B) monthly online training and discussion through skype and zoom, to allow for physical demonstrations, Q\&A and sharing of challenges. The five specific areas covered in the intervention for COVID-19 preventive protocols will include: (1) PPE fitting, (2) PPE removal, (3) hand hygiene, (4) cleaning, disinfection and sterilization, and (5) nurse uniform sterilization.
Study: NCT04584372

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: High-nitrate intervention
Description: The 2×70 mL of nitrate-rich (i.e., 'high nitrate') beetroot juice contains 12.9 mmol nitrate (NO3-).

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Low-nitrate intervention
Description: The 2×70 mL of nitrate-depleted (i.e., 'low nitrate') beetroot juice contains 0.04 mmol (or less) nitrate.
Study: NCT05364047

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Low-dose of LVRNA009
Description: 25μg/person

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Low-dose of LVRNA009
Description: 25μg/person

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Middle-dose of LVRNA009
Description: 50μg/person

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Middle-dose of LVRNA009
Description: 50μg/person

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: High-dose of LVRNA009
Description: 100μg/person
Study: NCT05162885

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Socket Preservation technique
Description: Implant placement after Socket preservation Technique with sodium alderonate versus sticky bone in salama\&salama Class 3 labial wall defect

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Socket Preservation technique
Description: Implant placement after Socket preservation Technique with sodium alderonate versus sticky bone in salama\&salama Class 3 labial wall defect
Study: NCT04945161

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ON101 Cream
Description: Active ingredients: Extracts of Plectranthus amboinicus and Centella Asiatica

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05997485

Intervention type: DRUG
Intervention: Nirmatrelvir/Ritonavir
Description: Patients administered oral Paxlovid as prescribed according to national Morocco treatment guidelines for Covid.
Study: NCT02684383

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rDEN3∆30
Description: 10\^3 plaque-forming units (PFUs); administered by subcutaneous injection in the deltoid region of the upper arm

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered by subcutaneous injection in the deltoid region of the upper arm
Study: NCT05131997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AD-221
Description: PO, Once daily(QD), 8 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AD-221A
Description: PO, Once daily(QD), 8 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AD-221B
Description: PO, Once daily(QD), 8 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AD-221C
Description: PO, Once daily(QD), 8 weeks
Study: NCT06539819

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electrical Posterior Box Isolation and Rotor Modulation Ablation group (R&B group)
Description: the intervention is conducting electrical posterior box isolation plus rotor modulation ablation

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Electrical Posterior Box Isolation group (BO group)
Description: the intervention is conducting electrical posterior box isolation alone
Study: NCT04768764

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided Middle Adductor Canal Block
Description: Middle adductor canal block will be applied post-operatively with guidance of USG.~Drug:Bupivacaine 0.25% Injectable Solution

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound Guided Femoral Nerve Block.
Description: Femoral nerve block will be applied post-operatively with guidance of USG. Drug:Bupivacaine 0.25% Injectable Solution

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: 10 ml %0,5 Bupivacaine will be diluted with 10 ml saline solution. Bupivacaine 0.25% Injectable Solution

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: 10 ml %0,5 Bupivacaine will be diluted with 10 ml saline solution. Bupivacaine 0.25% Injectable Solution

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Anesthesia
Description: Patients will be placed in the lateral decubitus position.Subarachnoid space will be entered through the most suitable intervertebral space.Bupivacaine 0.5% Heavy will be given in the appropriate dose.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Spinal Anesthesia
Description: Patients will be placed in the lateral decubitus position.Subarachnoid space will be entered through the most suitable intervertebral space.Bupivacaine 0.5% Heavy will be given in the appropriate dose.
Study: NCT05285332

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgical treatment 1
Description: Mastectomy OR Breast conserving surgery

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgical treatment 1
Description: Mastectomy OR Breast conserving surgery

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgical treatment 2
Description: Resection of metastasis

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Systemic therapy
Description: Endocrine therapy or chemotherapy or targeted therapy
Study: NCT04881591

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treatment as usual + APP
Description: Participants at this condition will receive the usual medical treatment for their scoliosis but also they will be monitored daily using the Scoliosis Pain Monitor APP. Alarms will be generated in the face of certain preestablished undesired events. Physicians will be asked to call patients and change/stop treatment if an alarm is received.
Study: NCT06156228

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multilevel Intervention
Description: Clinic patients from the randomly assigned intervention clinics will be provided with additional vaccine information and will have the opportunity to ask any questions they might have about any of the 4 study focused vaccines (COVID-19, Shingles, Pneumococcal, Influenza). Health educators will provide them with additional information, address any misinformation and disinformation and will offer to schedule their vaccine appointment(s) for them.
Study: NCT06174519

Intervention type: DEVICE
Intervention: Medical device simulation
Description: For the subjects included, investigators used the iAST® tool to predict which antibiotics would have been recommended as the top three choices both for empiric and semi-targeted therapy and recorded this data with the percentage of coverage predicted (the first three antibiotics in the iAST® ranking that have been tested in the antibiogram of the center where the study was carried were chosen). Investigators checked the final microbiological reports and logged if the recovered bacteria were susceptible to the drug prescribed by doctors and simulated by the iAST® tool according to the final antibiogram results.
Study: NCT05033015

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mouth rinse
Description: To test a novel mouth rinse containing enzymes to prevent development of WSL with a control

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mouth rinse
Description: To test a novel mouth rinse containing enzymes to prevent development of WSL with a control
Study: NCT05620680

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD7 CAR-T cells
Description: patient was subjected to 0.5-2×10\^6 cells/kg of CD7 CAR- T
Study: NCT06250400

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: human histaglobulin
Description: once 12 mg/2ml/bottle, 2 subcutaneous injection once a week, using 4 times in a row, a total of 28 d;

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: once 12 mg/2ml/bottle, 2 subcutaneous injection once a week, using 4 times in a row, a total of 28 d;

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Loratadine 10 Mg
Description: orally, 10mg once a day for 4 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Loratadine 10 Mg
Description: orally, 10mg once a day for 4 weeks
Study: NCT04661566

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.
Study: NCT04695834

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Neurolysis peroneal nerve
Description: The surgical approach for entrapment at the fibular head is usually through a curvilinear incision just distal to the fibular head. The subcutaneous tissue is bluntly dissected, and the common peroneal nerve is identified proximal to the peroneus longus muscle. The peroneal nerve is then released from the surrounding fibrous tissue and fascia. The nerve is decompressed distally as it dives under the peroneus longus muscle. The decompression at this site is essential. Certain authors state that an adequate decompression should extend beyond the bifurcation in the deep and superficial peroneal nerve and should involve cutting the intermuscular septa
Study: NCT04661566

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Basic Education (Education)
Description: All participants will receive the basic educational component in the Mission Wellness app. This component will contain text and media (e.g., images, videos) to teach basic SRH topics. The exact information in this component will be determined by an assessment of baseline SRH knowledge at the start of the intervention.
Study: NCT05364047

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: High-dose of LVRNA009
Description: 100μg/person

Intervention type: OTHER
Group type: OTHER
Intervention: Placebo
Description: 0.5ml/person